Get in on Invesco Ltd.’s (IVZ) buy-in window today!

Invesco Ltd. (NYSE: IVZ) stock fell -1.86% on Wednesday to $14.78 against a previous-day closing price of $15.06. With 4.41 million shares changed hands, the volume of the stock remained lighter than its average volume of 4.68 million shares. During the session, the Asset Management company that operates in wider Financial sector, reached to the highest price of $14.93 whereas the lowest price it dropped to was $14.52. The 52-week range on IVZ shows that it touched its highest point at $20.56 and its lowest point at $13.20 during that stretch. It currently has a 1-year price target of $17.79. With its current market cap of 6.81 billion, IVZ has annualized dividend of $0.80 while the current yield stands at 5.41%. Beta for the stock currently stands at 1.35.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of IVZ was down-trending over the past week, with a drop of -2.83%, but this was down by -12.02% over a month. Three-month performance dropped to -16.69% while six-month performance fell -21.84%. The stock lost -20.96% in the past year, while it has lost -17.84% so far this year. A look at the trailing 12-month EPS for IVZ yields 1.38 with Next year EPS estimates of 1.95. For the next quarter, that number is 0.39. This implies an EPS growth rate of -50.30% for this year and 15.63% for next year. EPS is expected to grow by 11.78% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -9.30%.

Float and Shares Shorts:

At present, 458.10 million IVZ shares are outstanding with a float of 367.07 million shares on hand for trading. On Apr 27, 2023, short shares totaled 11.41 million, which was 2.49% higher than short shares on Mar 30, 2023. In addition to Mr. Martin L. Flanagan CFA, CPA as the firm’s Pres, CEO & Director, Ms. Laura Allison Dukes serves as its Sr. MD & CFO.

Institutional Ownership:

Through their ownership of 86.08% of IVZ’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 48.30% of IVZ, in contrast to 39.32% held by mutual funds. Shares owned by individuals account for 29.82%. As the largest shareholder in IVZ with 17.89% of the stake, Massachusetts Mutual Life Insuran holds 81,332,319 shares worth 81,332,319. A second-largest stockholder of IVZ, The Vanguard Group, Inc., holds 51,848,122 shares, controlling over 11.40% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in IVZ, holding 34,372,565 shares or 7.56% stake. With a 3.11% stake in IVZ, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 14,128,972 shares are owned by the mutual fund manager. The Vanguard Small Cap Index Fund, which owns about 2.62% of IVZ stock, is the second-largest Mutual Fund holder. It holds 11,896,818 shares valued at 203.79 million. iShares Tr. – Select Dividend ETF holds 2.57% of the stake in IVZ, owning 11,682,056 shares worth 200.11 million.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, IVZ reported revenue of $1.53B and operating income of $344.90M. The EBITDA in the recently reported quarter was $322.70M and diluted EPS was $0.26.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for IVZ since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With IVZ analysts setting a high price target of $21.00 and a low target of $15.00, the average target price over the next 12 months is $17.68. Based on these targets, IVZ could surge 42.08% to reach the target high and rise by 1.49% to reach the target low. Reaching the average price target will result in a growth of 19.62% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded IVZ stock several times over the past three months with 19 Buys and 11 Sells. In these transactions, 1,007,258 shares were bought while 504,704 shares were sold. The number of buy transactions has increased to 32 while that of sell transactions has risen to 27 over the past year. The total number of shares bought during that period was 3,034,748 while 11,145,216 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *